Dietschy J M
J Clin Invest. 1968 Feb;47(2):286-300. doi: 10.1172/JCI105725.
According to current concepts, the liver and gastrointestinal tract are considered to be the major, if not the sole, sources of circulating serum cholesterol. While several mechanisms have been described which control the rate of hepatic cholesterogenesis, only biliary diversion is known to alter the rate of sterol synthesis in the intestine. The present study was designed to identify the inhibitory constituent of bile and to define its anatomic and biochemical sites of action. After either biliary diversion or cholestyramine feeding, there is a marked enhancement of cholesterogenesis at every level of the small intestine; this effect is specific for sterol synthesis since acetate incorporation into fatty acids and CO(2) is unaffected by these experimental manipulations. In the present investigation bile salt has been shown to be the constituent of whole bile responsible for the inhibited rate of sterol synthesis found in the intact animal, and in addition, an inverse relationship has been shown to exist between the steady-state intraluminal bile salt concentration and the rate of cholesterogenesis in the adjacent bowel wall. The inhibitory effect of bile salt is directed at the cells of the intestinal crypt, the major anatomic site for sterol synthesis in the small bowel. This feedback inhibition has been localized in the biosynthetic sequence to a step between acetyl CoA and mevalonic acid and, presumably, is at the enzymatic step mediated by hydroxymethylglutaryl reductase. These studies emphasize the close interrelationship which exists between the mechanisms of control of cholesterogenesis in the liver and small intestine. Sterol synthesis in the liver is regulated by exogenous cholesterol intake, whereas the rate of intestinal sterol synthesis is controlled by bile salt, the major end product of the hepatic catabolism of cholesterol.
根据当前的概念,肝脏和胃肠道被认为是循环血清胆固醇的主要来源,即便不是唯一来源。虽然已经描述了几种控制肝脏胆固醇生成速率的机制,但已知只有胆汁分流会改变肠道中甾醇合成的速率。本研究旨在鉴定胆汁中的抑制成分,并确定其解剖学和生化作用位点。在进行胆汁分流或给予消胆胺后,小肠各部位的胆固醇生成均显著增强;这种作用对甾醇合成具有特异性,因为乙酸掺入脂肪酸和二氧化碳的过程不受这些实验操作的影响。在本研究中,胆汁盐已被证明是全胆汁中导致完整动物体内甾醇合成速率受到抑制的成分,此外,还显示出管腔内胆汁盐稳态浓度与相邻肠壁中胆固醇生成速率之间存在反比关系。胆汁盐的抑制作用针对肠隐窝细胞,这是小肠中甾醇合成的主要解剖学部位。这种反馈抑制在生物合成序列中已定位到乙酰辅酶A与甲羟戊酸之间的一个步骤,推测是在由羟甲基戊二酰辅酶A还原酶介导的酶促步骤。这些研究强调了肝脏和小肠中胆固醇生成控制机制之间存在的密切相互关系。肝脏中的甾醇合成受外源性胆固醇摄入的调节,而肠道甾醇合成的速率则由胆汁盐控制,胆汁盐是肝脏胆固醇分解代谢的主要终产物。